Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

'Coin Stories' host Natalie Brunell shares Bitcoin basics and tips

Check out the above video for Bitcoin Basics with “Coin Stories” podcast host and Bitcoin expert Natalie Brunell . In this must-watch interview, Brunell breaks down the basics of Bitcoin saying, “anyone can learn” and tha...

Why Fortune Favours Chris Taylor’s Kodiak Copper

It’s a stark new reality. And investors need to listen up or lose out. Truth be told, it is no longer only the size and grade of each new mineral discovery that determines whether it can become a mine. Now, all exploration/development projects also need to ...

Canagold: Sweet Surprise as a High-Grade Low-Cost Gold Deposit Delivers

It’s a big shot in the arm that promises to redouble the considerable scarcity value of the New Polaris gold deposit. A one-million-ounce gold deposit that is owned by Canagold Resources ( TSX: CCM ) (OTCBB: CRCUF) ( Frankfurt: CANA), New Polaris may be ...

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID-19 and other coronaviruses – including future outbreaks. And it is not getting any less resonant as new variants continue to cause ha...

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTCQB: XPHYF) has earned considerable media coverage in recent months due to its expansion into the development of psychedelic d...

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...

Why the US is Backing American Lithium

It’s a strategically symbolic investment that clearly demonstrates the US government’s determination to break China’s dominance of the global lithium trade. Now that lithium has been declared as critical to America&CloseCurly...

Sierra Madre Gold & Silver: Mining’s Next Star Performer?

As the US economy bounces back, confident and emboldened investors are rushing back into speculative stocks and cryptocurrencies (like Bitcoin) with a view to making outsized financial gains. Lately, it’s been a dominant media...
1 2 3 4 5